P&K Skin Research Center Co., Ltd. (KOSDAQ: 347740)

P&K Skin Research Center Statistics

Total Valuation

P&K Skin Research Center has a market cap or net worth of KRW 74.94 billion. The enterprise value is 28.21 billion.

Market Cap	74.94B
Enterprise Value	28.21B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

P&K Skin Research Center has 29.10 million shares outstanding. The number of shares has decreased by -0.96% in one year.

Shares Outstanding	29.10M
Shares Change (YoY)	-0.96%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	3.60%
Owned by Institutions (%)	n/a
Float	11.27M

Valuation Ratios

The trailing PE ratio is 14.26.

PE Ratio	14.26
Forward PE	n/a
PS Ratio	4.69
PB Ratio	1.01
P/FCF Ratio	12.91
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.16, with an EV/FCF ratio of 4.86.

EV / Earnings	5.27
EV / Sales	1.73
EV / EBITDA	7.16
EV / EBIT	13.32
EV / FCF	4.86

Financial Position

The company has a current ratio of 19.18, with a Debt / Equity ratio of 0.01.

Current Ratio	19.18
Quick Ratio	17.32
Debt / Equity	0.01
Debt / EBITDA	0.12
Debt / FCF	0.08
Interest Coverage	68.62

Financial Efficiency

Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 1.80%.

Return on Equity (ROE)	7.20%
Return on Assets (ROA)	1.74%
Return on Capital (ROIC)	1.80%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.83% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.83%
50-Day Moving Average	2,609.20
200-Day Moving Average	2,754.33
Relative Strength Index (RSI)	46.62
Average Volume (20 Days)	514,402

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, P&K Skin Research Center had revenue of KRW 16.28 billion and earned 5.36 billion in profits. Earnings per share was 180.58.

Revenue	16.28B
Gross Profit	7.98B
Operating Income	2.12B
Pretax Income	6.14B
Net Income	5.36B
EBITDA	3.94B
EBIT	2.12B
Earnings Per Share (EPS)	180.58

Balance Sheet

The company has 47.17 billion in cash and 467.65 million in debt, giving a net cash position of 46.70 billion or 1,604.74 per share.

Cash & Cash Equivalents	47.17B
Total Debt	467.65M
Net Cash	46.70B
Net Cash Per Share	1,604.74
Equity (Book Value)	73.48B
Book Value Per Share	2,545.32
Working Capital	51.67B

Cash Flow

In the last 12 months, operating cash flow was 6.93 billion and capital expenditures -1.12 billion, giving a free cash flow of 5.81 billion.

Operating Cash Flow	6.93B
Capital Expenditures	-1.12B
Free Cash Flow	5.81B
FCF Per Share	199.47

Margins

Gross margin is 48.98%, with operating and profit margins of 13.01% and 32.89%.

Gross Margin	48.98%
Operating Margin	13.01%
Pretax Margin	37.68%
Profit Margin	32.89%
EBITDA Margin	24.21%
EBIT Margin	13.01%
FCF Margin	35.65%

Dividends & Yields

This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 1.16%.

Dividend Per Share	30.00
Dividend Yield	1.16%
Dividend Growth (YoY)	-14.29%
Years of Dividend Growth	n/a
Payout Ratio	13.34%
Buyback Yield	0.96%
Shareholder Yield	2.13%
Earnings Yield	7.01%
FCF Yield	7.75%

Stock Splits

The last stock split was on July 26, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jul 26, 2022
Split Type	Forward
Split Ratio	4

Scores

P&K Skin Research Center has an Altman Z-Score of 16.83.

Altman Z-Score	16.83
Piotroski F-Score	n/a